Bioventus Inc. (BVS)
USD 8.27
(-9.62%)
USD 8.27
(-9.62%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 512.34 Million USD | 0.04% |
| 2022 | 512.11 Million USD | 18.85% |
| 2021 | 430.89 Million USD | 34.17% |
| 2020 | 321.16 Million USD | -5.58% |
| 2019 | 340.14 Million USD | 6.57% |
| 2018 | 319.17 Million USD | 9.29% |
| 2017 | 292.05 Million USD | 6.4% |
| 2016 | 274.5 Million USD | 8.22% |
| 2015 | 253.65 Million USD | 4.43% |
| 2014 | 242.89 Million USD | 4.53% |
| 2013 | 232.37 Million USD | 0.0% |
| 1999 | 64.77 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 151.21 Million USD | 16.81% |
| 2024 Q3 | 138.96 Million USD | -8.1% |
| 2024 Q1 | 129.45 Million USD | -4.41% |
| 2023 FY | 512.34 Million USD | 0.04% |
| 2023 Q1 | 119.05 Million USD | -5.38% |
| 2023 Q2 | 137.06 Million USD | 15.13% |
| 2023 Q3 | 120.79 Million USD | -11.87% |
| 2023 Q4 | 135.42 Million USD | 12.11% |
| 2022 Q4 | 125.83 Million USD | -2.2% |
| 2022 Q1 | 117.29 Million USD | -10.06% |
| 2022 Q2 | 140.33 Million USD | 19.64% |
| 2022 FY | 512.11 Million USD | 18.85% |
| 2022 Q3 | 128.66 Million USD | -8.32% |
| 2021 FY | 430.89 Million USD | 34.17% |
| 2021 Q1 | 81.77 Million USD | -17.05% |
| 2021 Q4 | 130.41 Million USD | 19.77% |
| 2021 Q3 | 108.89 Million USD | -0.84% |
| 2021 Q2 | 109.81 Million USD | 34.29% |
| 2020 Q1 | 78.64 Million USD | -19.38% |
| 2020 FY | 321.16 Million USD | -5.58% |
| 2020 Q4 | 98.59 Million USD | 14.76% |
| 2020 Q3 | 85.9 Million USD | 48.07% |
| 2020 Q2 | 58.01 Million USD | -26.23% |
| 2019 Q3 | 82.24 Million USD | 2.58% |
| 2019 FY | 340.14 Million USD | 6.57% |
| 2019 Q2 | 80.17 Million USD | 0.0% |
| 2019 Q1 | 80.17 Million USD | 0.0% |
| 2019 Q4 | 97.55 Million USD | 18.62% |
| 2018 FY | 319.17 Million USD | 9.29% |
| 2017 FY | 292.05 Million USD | 6.4% |
| 2016 Q1 | 65.4 Million USD | 0.0% |
| 2016 FY | 274.5 Million USD | 8.22% |
| 2015 Q1 | 53.36 Million USD | 0.0% |
| 2015 FY | 253.65 Million USD | 4.43% |
| 2014 FY | 242.89 Million USD | 4.53% |
| 2013 FY | 232.37 Million USD | 0.0% |
| 1999 FY | 64.77 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -4148.652% |
| BrainsWay Ltd. | 31.78 Million USD | -1511.908% |
| Cerus Corporation | 156.36 Million USD | -227.655% |
| Envoy Medical, Inc. | 316 Thousand USD | -162034.494% |
| electroCore, Inc. | 16.03 Million USD | -3096.163% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -79456.677% |
| IceCure Medical Ltd | 3.22 Million USD | -15766.987% |
| Inogen, Inc. | 315.66 Million USD | -62.309% |
| OrthoPediatrics Corp. | 148.73 Million USD | -244.475% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -21001.524% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -140268.878% |
| MaxCyte, Inc. | 41.28 Million USD | -1140.905% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -26141.254% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -462522.35% |
| Orthofix Medical Inc. | 746.64 Million USD | 31.38% |
| PAVmed Inc | 2.45 Million USD | -20794.984% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -2175.168% |
| RxSight, Inc. | 89.07 Million USD | -475.171% |
| Sight Sciences, Inc. | 81.05 Million USD | -532.088% |
| SI-BONE, Inc. | 138.88 Million USD | -268.896% |
| TELA Bio, Inc. | 58.45 Million USD | -776.508% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | -173.809% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -3612.376% |
| Acutus Medical, Inc. | 7.16 Million USD | -7051.661% |
| Talis Biomedical Corporation | 412 Thousand USD | -124255.583% |
| Spectral AI, Inc. | 18.05 Million USD | -2737.533% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -5072.59% |
| CVRx, Inc. | 39.29 Million USD | -1203.843% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -52789.628% |
| Venus Concept Inc. | 76.35 Million USD | -571.013% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -2667.787% |
| LivaNova PLC | 1.15 Billion USD | 55.585% |
| 908 Devices Inc. | 50.22 Million USD | -920.018% |
| Alphatec Holdings, Inc. | 482.26 Million USD | -6.238% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -664903.115% |
| NeuroPace, Inc. | 65.42 Million USD | -683.151% |
| LENSAR, Inc. | 42.16 Million USD | -1115.124% |
| Apyx Medical Corporation | 52.34 Million USD | -878.71% |
| Cutera, Inc. | 212.36 Million USD | -141.252% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -1435.898% |
| BioSig Technologies, Inc. | 18 Thousand USD | -2846261.111% |
| Anika Therapeutics, Inc. | 166.66 Million USD | -207.416% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -2038.781% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 66.765% |
| Axonics, Inc. | 366.37 Million USD | -39.84% |
| Outset Medical, Inc. | 130.37 Million USD | -292.975% |
| IRIDEX Corporation | 51.86 Million USD | -887.767% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | -276.196% |
| IRadimed Corporation | 65.56 Million USD | -681.463% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -43466.752% |
| INVO Bioscience, Inc. | 3.02 Million USD | -16861.837% |
| Telesis Bio, Inc. | 27.5 Million USD | -1762.463% |
| Viemed Healthcare, Inc. | 183 Million USD | -179.958% |
| Varex Imaging Corporation | 811 Million USD | 36.826% |
| Quipt Home Medical Corp. | 221.74 Million USD | -131.055% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | -646.043% |
| Dynatronics Corporation | 32.53 Million USD | -1474.8% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -5803.953% |
| Semler Scientific, Inc. | 68.18 Million USD | -651.415% |
| InMode Ltd. | 492.04 Million USD | -4.125% |
| Bruker Corporation | 2.96 Billion USD | 82.717% |
| Cytosorbents Corporation | 36.34 Million USD | -1309.501% |
| DexCom, Inc. | 3.62 Billion USD | 85.856% |
| Align Technology, Inc. | 3.86 Billion USD | 86.735% |
| Viveve Medical, Inc. | 6.42 Million USD | -7873.0% |
| ZimVie Inc. | 457.43 Million USD | -12.004% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | -165.443% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -462522.35% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 31.479% |
| Profound Medical Corp. | 7.33 Million USD | -6888.726% |
| Insulet Corporation | 1.69 Billion USD | 69.811% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | -306.371% |
| iCAD, Inc. | 17.31 Million USD | -2858.454% |
| Nuwellis, Inc. | 8.86 Million USD | -5680.065% |
| Biotricity, Inc. | 12.06 Million USD | -4147.122% |
| iRhythm Technologies, Inc. | 492.68 Million USD | -3.991% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -8156.97% |
| PAVmed Inc. | 2.45 Million USD | -20794.984% |
| BIOLASE, Inc. | 49.16 Million USD | -942.114% |
| Beyond Air, Inc. | 1.15 Million USD | -44105.781% |
| FONAR Corporation | 102.88 Million USD | -397.983% |
| AxoGen, Inc. | 159.01 Million USD | -222.205% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | -86.699% |
| Inari Medical, Inc. | 493.63 Million USD | -3.791% |
| UFP Technologies, Inc. | 400.07 Million USD | -28.063% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -2754443.011% |
| Tenon Medical, Inc. | 2.92 Million USD | -17398.122% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -7421.171% |
| AdaptHealth Corp. | 3.2 Billion USD | 83.99% |
| Sintx Technologies, Inc. | 2.62 Million USD | -19403.045% |
| NanoVibronix, Inc. | 2.28 Million USD | -22341.743% |
| Quanterix Corporation | 122.36 Million USD | -318.692% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -1999.344% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | -155.507% |
| TransMedics Group, Inc. | 241.62 Million USD | -112.043% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -3598.174% |
| NeuroMetrix, Inc. | 5.9 Million USD | -8581.717% |
| Hyperfine, Inc. | 11.03 Million USD | -4544.172% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | -210.228% |
| Biomerica, Inc. | 5.41 Million USD | -9361.588% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -913.32% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | -189.241% |